Cigna Corp (CI)

NYSE
Currency in USD
320.94
+12.08(+3.91%)
Closed·
Pre Market
319.20-1.74(-0.54%)
·
CI Scorecard
Full Analysis
Management has been aggressively buying back shares
CI is not included in our AI-picked strategies. See which stocks are.
Fair Value
Day's Range
307.78320.97
52 wk Range
262.03370.83
Key Statistics
Edit
Prev. Close
320.94
Open
309.4
Day's Range
307.78-320.97
52 wk Range
262.03-370.83
Volume
2.06M
Average Volume (3m)
1.87M
1-Year Change
-5.25%
Book Value / Share
148.38
Fair Value
unlockUnlock
Fair Value Upside
unlockUnlock
CI Scorecardpro icon
Company’s Health
Unlock
Fair Value
Unlock Price
Fair Price
Upside
Price Target
375.13
Upside
+16.89%
Members' Sentiments
Bearish
Bullish
ProTips
High shareholder yield
Show more

Cigna Corp Company Profile

The Cigna Group, together with its subsidiaries, provides insurance and related products and services in the United States. Its Evernorth Health Services segment provides a range of coordinated and point solution health services, including pharmacy benefits, home delivery pharmacy, specialty pharmacy, distribution, and care delivery and management solutions to health plans, employers, government organizations, and health care providers. The company’s Cigna Healthcare segment offers medical, pharmacy, behavioral health, dental, and other products and services for insured and self-insured customers; Medicare Advantage, Medicare Supplement, and Medicare Part D plans for seniors, as well as individual health insurance plans; and health care coverage in its international markets, as well as health care benefits for mobile individuals and employees of multinational organizations. In addition, it offers permanent insurance contracts sold to corporations to provide coverage on the lives of certain employees for financing employer-paid future benefit obligations and stop loss insurance. The company distributes its products and services through insurance brokers and consultants; directly to employers, unions and other groups, or individuals; and private and public exchanges. The company was formerly known as Cigna Corporation and changed its name to The Cigna Group in February 2023. The company was founded in 1792 and is headquartered in Bloomfield, Connecticut.

Cigna Corp SWOT Analysis


Financial Crossroads
Cigna faces challenges with increased high-cost claims, adjusting EPS guidance downward, while core businesses show resilience in a complex healthcare landscape
Strategic Positioning
Explore Cigna's strong market presence in PBM and specialty drugs, and its focus on biosimilars as key growth drivers amidst industry evolution
Merger Speculation
Delve into the potential Cigna-Humana merger, offering strategic advantages but presenting risks of shareholder approval and prolonged uncertainty
Future Outlook
Analyst price targets range from $339 to $420, reflecting varied perspectives on Cigna's ability to navigate industry trends and capitalize on opportunities
Read full SWOT analysis

Cigna Corp Earnings Call Summary for Q1/2025

  • Cigna Q1 2025 EPS of $6.74 beat $6.35 forecast; revenue of $65.5B exceeded $60.38B estimate; stock rose 2.4% to $343.24 pre-market
  • Full-year 2025 EPS guidance raised to at least $29.60; company projects 10-14% compounded EPS growth driven by healthcare innovation
  • Strategic initiatives include biosimilars launch, GLP-1 drug management solutions, and completion of Medicare business divestiture to HCSC
  • CEO David Cordani confident in sustainable growth; company focusing on specialty pharmacy expansion and cost management
  • Risks include regulatory changes in pharmacy benefit management, increasing specialty drug market competition, and economic uncertainties
Last Updated: 02/05/2025, 14:54
Read Full Transcript

Compare CI to Peers and Sector

Metrics to compare
CI
Peers
Sector
Relationship
P/E Ratio
17.0x15.3x−0.5x
PEG Ratio
0.370.000.00
Price/Book
2.1x2.0x2.6x
Price / LTM Sales
0.3x1.4x3.0x
Upside (Analyst Target)
16.7%21.1%54.1%
Fair Value Upside
Unlock21.7%8.7%Unlock

Analyst Ratings

18 Buy
6 Hold
0 Sell
Ratings:
24 analysts
Overall Consensus
Buy

Analysts 12-Month Price Target:

Average 375.13
(+16.89% Upside)

Dividends

Payout Ratio
Payout ratio (TTM)
Earnings retained
EPS 18.21%
Dividend Yield
1.88%
Industry Median 1.54%
Annualised payout
6.04
Paid quarterly
5-Years Growth
+169.72%
Growth Streak

Earnings

Latest Release
May 02, 2025
EPS / Forecast
6.74 / 6.35
Revenue / Forecast
65.50B / 60.38B
EPS Revisions
Last 90 days

People Also Watch

291.12
CEG
+2.36%
387.52
HCA
+0.52%
362.34
APP
-1.16%
156.62
VST
+3.00%
76.06
MRK
+1.68%

FAQ

What Stock Exchange Does Cigna Trade On?

Cigna is listed and trades on the New York Stock Exchange stock exchange.

What Is the Stock Symbol for Cigna?

The stock symbol for Cigna is "CI."

What Is the Cigna Market Cap?

As of today, Cigna market cap is 85.74B.

What Is Cigna's Earnings Per Share (TTM)?

The Cigna EPS (TTM) is 18.21.

When Is the Next Cigna Earnings Date?

Cigna will release its next earnings report on 30 Jul 2025.

From a Technical Analysis Perspective, Is CI a Buy or Sell?

Based on moving averages and other technical indicators, the daily buy/sell signal is Sell.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
© 2007-2025 - Fusion Media Limited. All Rights Reserved.